West Pharmaceutical Valuation
| WST Stock | USD 323.32 3.97 1.24% |
At this time, the company appears to be overvalued. West Pharmaceutical maintains a prevalent Real Value of $268.14 per share. The last-minute price of the company is $323.32. Our model calculates the value of West Pharmaceutical from examining the company fundamentals such as Current Valuation of 23.23 B, return on asset of 0.1, and Profit Margin of 0.17 % as well as analyzing its technical indicators and probability of bankruptcy. Key fundamental drivers impacting West Pharmaceutical's valuation include:
Price Book 8.5083 | Enterprise Value 23.2 B | Enterprise Value Ebitda 31.2057 | Price Sales 8.1406 | Forward PE 43.8596 |
Overvalued
Today
Please note that West Pharmaceutical's price fluctuation is very steady at this time. Calculation of the real value of West Pharmaceutical is based on 3 months time horizon. Increasing West Pharmaceutical's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
West Pharmaceutical's intrinsic value may or may not be the same as its current market price of 323.32, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 323.32 | Real 268.14 | Target 400.71 | Hype 323.32 | Naive 314.97 |
The intrinsic value of West Pharmaceutical's stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, news, and other external factors that may influence West Pharmaceutical's stock price. It is important to note that the real value of any stock may change over time based on changes in the company's performance.
Estimating the potential upside or downside of West Pharmaceutical Services helps investors to forecast how West stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of West Pharmaceutical more accurately as focusing exclusively on West Pharmaceutical's fundamentals will not take into account other important factors: Traditionally, analysts and sophisticated investors use multiple methods for valuing a cash-flow-generating entity or its stock. For example, some money managers use West Pharmaceutical's intrinsic value based on its ongoing forecasts of West Pharmaceutical's financial statements. In contrast, other private, professional wealth advisors use a multiplier approach by looking to relative value analysis against West Pharmaceutical's closest peers.
West Pharmaceutical Cash |
|
West Valuation Trend
West Pharmaceutical's real value is important for investors to make better decisions and a more accurate overall view of West Pharmaceutical's financial worth over time. Using both West Pharmaceutical's enterprise value as well as its market capitalization is the best way to gauge the value of the company and is usually enough for investors to make market timing conclusions.
West Pharmaceutical Total Value Analysis
West Pharmaceutical Services is at this time projected to have company total value of 23.23 B with market capitalization of 23.42 B, debt of 309 M, and cash on hands of 894.3 M. Please note that company total value may be misleading and is a subject to accounting gimmicks. We encourage investors to carefully check all of the West Pharmaceutical fundamentals before making security assessment based on enterprise value of the company| Takeover Price | Market Cap | Debt Obligations | Cash |
23.23 B | 23.42 B | 309 M | 894.3 M |
West Pharmaceutical Investor Information
About 97.0% of the company outstanding shares are owned by institutional investors. The company recorded earning per share (EPS) of 6.73. West Pharmaceutical last dividend was issued on the 13th of November 2024. The entity had 2:1 split on the 27th of September 2013. Based on the analysis of West Pharmaceutical's profitability, liquidity, and operating efficiency, West Pharmaceutical Services is performing exceptionally good at this time. It has a great probability to report excellent financial results in December.| Current Value | Last Year | Change From Last Year | 10 Year Trend | ||||||
|---|---|---|---|---|---|---|---|---|---|
| Operating Profit Margin | 0.24 | 0.2292 |
|
| |||||
| Total Cash From Operating Activities | 815.3 M | 776.5 M |
|
| |||||
| Operating Income | 709.8 M | 676 M |
|
|
West Pharmaceutical Asset Utilization
The asset utilization indicator refers to the revenue earned for every dollar of assets a company currently reports. West Pharmaceutical has an asset utilization ratio of 77.03 percent. This implies that the Company is making $0.77 for each dollar of assets. An increasing asset utilization means that West Pharmaceutical Services is more efficient with each dollar of assets it utilizes for everyday operations.West Pharmaceutical Ownership Allocation
West Pharmaceutical Services retains a total of 72.42 Million outstanding shares. The majority of West Pharmaceutical outstanding shares are owned by institutional investors. These institutions are usually referred to as non-private investors looking to purchase positions in West Pharmaceutical to benefit from reduced commissions. Consequently, other corporate entities are subject to a different set of regulations than regular investors in West Pharmaceutical Services. Please pay attention to any change in the institutional holdings of West Pharmaceutical as this could imply that something significant has changed or is about to change at the company. Please note that on October 8, 2024, Representative Ro Khanna of US Congress acquired under $15k worth of West Pharmaceutical's common stock.West Pharmaceutical Profitability Analysis
The company reported the last year's revenue of 2.95 B. Total Income to common stockholders was 593.4 M with profit before taxes, overhead, and interest of 1.14 B.West Pharmaceutical Past Distributions to stockholders
About West Pharmaceutical Valuation
The stock valuation mechanism determines West Pharmaceutical's current worth on a daily basis. In general, an absolute valuation approach attempts to find the value of West Pharmaceutical based exclusively on its fundamental and basic technical indicators. As compared to an absolute model, our relative valuation model uses a comparative analysis of West Pharmaceutical. We calculate exposure to West Pharmaceutical's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of West Pharmaceutical's related companies.| Last Reported | Projected for Next Year | ||
| Gross Profit | 1.1 B | 1.2 B | |
| Pretax Profit Margin | 0.24 | 0.25 | |
| Operating Profit Margin | 0.23 | 0.24 | |
| Net Profit Margin | 0.20 | 0.21 | |
| Gross Profit Margin | 0.38 | 0.26 |
West Pharmaceutical Quarterly Retained Earnings |
|
A single share of West Pharmaceutical represents a small ownership stake in the entity. As a stockholder of West, your percentage of company ownership is determined by dividing the number of shares you own by the total number of shares outstanding and then multiplying that amount by 100. Owning stock in a company generally confers both corporate voting rights and income from any dividends paid to the stock owner.
West Pharmaceutical Dividends Analysis For Valuation
Dividends Paid is likely to gain to about 59.9 M in 2024, whereas Dividend Yield is likely to drop 0 in 2024. . At this time, West Pharmaceutical's Retained Earnings are comparatively stable compared to the past year. Retained Earnings Total Equity is likely to gain to about 3.6 B in 2024, whereas Earnings Yield is likely to drop 0.02 in 2024.
| Last Reported | Projected for Next Year | ||
| Dividends Paid | 57 M | 59.9 M | |
| Dividend Payout Ratio | 0.10 | 0.09 | |
| Dividend Paid And Capex Coverage Ratio | 1.85 | 1.03 |
There are various types of dividends West Pharmaceutical can pay to its shareholders, and the actual value of the dividend is determined on a per-share basis. It is to be paid equally to all of West shareholders on a specific date, known as the payable date. The cash dividend is the most common type of dividend payment - it is the payment of actual cash from West Pharmaceutical Services directly to its shareholders. There are other types of dividends that companies can issue, such as stock dividends or asset dividends. When West pays a dividend, it has no impact on its enterprise value. It does, however, lowers the Equity Value of West Pharmaceutical by the value of the dividends paid out.
West Pharmaceutical Growth Indicators
Investing in growth stocks can be very risky. If the company such as West Pharmaceutical does not do well, investors take a loss on the stock when it is time to sell. Also, because growth stocks typically do not pay dividends, the only opportunity an investor has to make money on their investment is when they eventually sell their shares.
| Common Stock Shares Outstanding | 75.3 M | |
| Quarterly Earnings Growth Y O Y | -0.136 | |
| Forward Price Earnings | 43.8596 |
West Pharmaceutical Current Valuation Indicators
West Pharmaceutical's valuation analysis is a process of estimating the intrinsic value of all assets and outstanding equities. There are different methodologies and models we use to develop the final West Pharmaceutical's valuation. The techniques such as discounted cash flow and fundamental indicators such as book value per share or market capitalization are well known and widely used across most financial advisers and money managers.
Valuations are an essential part of business, for companies themselves, but also for investors. For companies, such as West Pharmaceutical, valuations can help measure their progress and success and can help them track their performance in the market compared to others. In addition, investors can use West Pharmaceutical's valuations to help determine the worth of potential investments. They can do this by using data and information made public by a company. Regardless of who the valuation is for, it essentially describes West Pharmaceutical's worth.Additional Tools for West Stock Analysis
When running West Pharmaceutical's price analysis, check to measure West Pharmaceutical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy West Pharmaceutical is operating at the current time. Most of West Pharmaceutical's value examination focuses on studying past and present price action to predict the probability of West Pharmaceutical's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move West Pharmaceutical's price. Additionally, you may evaluate how the addition of West Pharmaceutical to your portfolios can decrease your overall portfolio volatility.